Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.48 |
| ▸ | FEN1 | P39748 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MYC | P01106 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | TYK2 | P29597 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3652206 | 0.81 | ESR1 (0.49) | HPGDHTTNPC1RAB9AMYC | |
| SCHEMBL9545865 | 0.81 | ALDH1A1 (0.53) | HPGDSMN1; SMN2KDM4EALDH1A1HSD17B10 | |
| SCHEMBL29387256 | 0.79 | CYP3A4 (0.55) | HPGDERCC5FEN1HTTSMN1; SMN2 | |
| SCHEMBL166603 | 0.79 | HPGD (0.54) | HPGDERCC5FEN1HTTSMN1; SMN2 | |
| SCHEMBL333141 | 0.79 | CYP3A4 (0.55) | HPGDERCC5FEN1HTTSMN1; SMN2 | |
| SCHEMBL29425530 | 0.79 | HPGD (0.54) | HPGDERCC5FEN1HTTSMN1; SMN2 | |
| SCHEMBL777261 | 0.78 | NPC1 (0.53) | HPGDERCC5FEN1HTTNPC1 | |
| SCHEMBL29436920 | 0.78 | NPC1 (0.53) | HPGDERCC5FEN1HTTNPC1 | |
| SCHEMBL127127 | 0.78 | NPC1 (0.53) | HPGDERCC5FEN1HTTNPC1 | |
| SCHEMBL11607257 | 0.78 | CYP1A2 (0.54) | HPGDMYCKDM4EALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110603250-A | Herbicidal 4-difluoromethylbenzamides | 拜耳作物科学股份公司 | 2019-12-20 | — | — | CN | claimed |
| EP-2182950-B1 | USE OF 4-(PYRROLIDIN-1-YL)QUINOLINE COMPOUNDS TO KILL CLINICALLY LATENT MICROORGANISMS | HELPERBY THERAPEUTICS LTD (GB) | 2017-07-19 | — | — | EP | claimed |
| EP-3116871-A1 | USE OF N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR THEIR SALTS FOR CONTROLLING UNWANTED PLANTS IN AREAS OF TRANSGENIC CROP PLANTS BEING TOLERANT TO HPPD INHIBITOR HERBICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2017-01-18 | — | — | EP | claimed |
| WO-2015135946-A1 | USE OF N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR THEIR SALTS FOR CONTROLLING UNWANTED PLANTS IN AREAS OF TRANSGENIC CROP PLANTS BEING TOLERANT TO HPPD INHIBITOR HERBICIDES | BAYER CROPSCIENCE AG (DE) | 2015-09-17 | — | — | WO | claimed |
| US-8765780-B2 | Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-07-01 | — | — | US | claimed |
| US-20060058553-A1 | Novel bicyclic hydroxamates as inhibitors of histone deacetylase | AXYS PHARMACEUTICALS, INC. (US) | 2006-03-16 | — | — | US | claimed |
| EP-1472216-A2 | NOVEL BICYCLIC HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | Axys Pharmaceuticals (US) | 2004-11-03 | — | — | EP | claimed |
| WO-2003066579-A2 | NOVEL BICYCLIC HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | AXYS PHARMACEUTICALS (US) | 2003-08-14 | — | — | WO | claimed |
| WO-2001092420-A2 | PERYLENE DYES WITH PERSISTENT FLUORESCENCE CAUSED BY STERIC INHIBITION OF AGGREGATION | RADIANT COLOR N.V. (BE) | 2001-12-06 | — | — | WO | claimed |
| US-6004536-A | USED FOR STAINING MEMBRANES IN CELLS OR ISOLATED FROM CELLS, ARE WELL-RETAINED THEREIN | MOLECULAR PROBES, INC. (US) | 1999-12-21 | — | — | US | claimed |
| EP-0446748-A2 | Use of perylenedyes for the preparation of write, print or copying materials | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1991-09-18 | — | — | EP | claimed |
| WO-2024121779-A1 | PAPAIN-LIKE PROTEASE (PLPRO) INHIBITORS | PFIZER INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| CN-113677773-B | Room temperature curable organopolysiloxane composition for oil seal and automobile part | 信越化学工业株式会社 | 2024-03-01 | — | — | CN | disclosed |
| CN-117425733-A | Substance detection method using acylated amino acid hydrolase | 学校法人常翔学园 | 2024-01-19 | — | — | CN | disclosed |
| EP-3661901-B1 | SYNTHESIS OF GLYCOLS VIA TRANSFER HYDROGENATION OF ALPHA-FUNCTIONAL ESTERS WITH ALCOHOLS | EASTMAN CHEM CO (US) | 2023-12-06 | — | — | EP | disclosed |
| EP-0094911-A2 | Preparation of pyrrolo-(3,4-c) pyrroles | CIBA-GEIGY AG (CH) | 1983-11-23 | — | — | EP | disclosed |
| US-4415685-A | POLYMERIC FLUORESCENT RED DYES; LACQUERS; TONERS; VARNISHES; FIBERS; PLASTICS; COLOR FASTNESS | CIBA-GEIGY CORPORATION (US) | 1983-11-15 | — | — | US | disclosed |
| EP-0061426-A1 | Process for colouring highly molecular organic material and polycyclic pigments | CIBA-GEIGY AG (CH) | 1982-09-29 | — | — | EP | disclosed |
| EP-0011849-B1 | 2,4,6-TRIIODO-ISOPHTHALAMIC ACID DERIVATIVES, THEIR PREPARATION AND X-RAY CONTRAST AGENTS BASED ON THESE COMPOUNDS | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-05-19 | — | — | EP | disclosed |
| EP-0001617-B1 | DIAZOTYPE MATERIAL | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-07-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058553-A1 | Novel bicyclic hydroxamates as inhibitors of histone deacetylase | HDAC1, HDAC2, HDAC11 | HPGD 188/4885ERCC5 2195/4885FEN1 2134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.